Výsledky vyhledávání - "ORIGINAL PAPERS: Therapeutic aspects"

A novel angiotensin II peptide vaccine without an adjuvant in mice

Autor: Jiao Sun, Akiko Tenma, Hiromi Rakugi, Ryuichi Morishita, Munehisa Shimamura, Koichi Yamamoto, Hiroki Hayashi, Ryo Nakamaru, Hironori Nakagami

Publikováno v: Journal of Hypertension

Objectives We recently developed a novel peptide, AJP001, that possesses both a mouse T-cell epitope and adjuvant action. Direct conjugation to the antigen is useful for peptide vaccines without the addition of adjuvants. In this study, the efficacy

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee6910a50c4b4a87b2c18d1bad55ed87
https://doi.org/10.1097/hjh.0000000000002597

Zobrazit plný text záznamu

Patients' and healthcare providers' perceptions and practices regarding hypertension, pharmacy-based care, and mHealth in Lagos, Nigeria

Autor: Heleen E. Nelissen, Akin Osibogun, Anja H. van’t Hoog, Abiola Alege, Anne Lia Cremers, Tochi J. Okwor, René Gerrets

Publikováno v: Journal of hypertension, 37(2), 389-397. Lippincott Williams and Wilkins
Journal of hypertension, 37(2), 389-397. Lippincott Williams & Wilkins
Journal of Hypertension

Background: In sub-Saharan Africa, cardiovascular disease is becoming a leading cause of death, with high blood pressure as number one risk factor. In Nigeria, access and adherence to hypertension care are poor. A pharmacy-based hypertension care mod

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31aeb3ddac34c741441ed34150bdacef
http://www.scopus.com/inward/record.url?scp=85057594795&partnerID=8YFLogxK

Zobrazit plný text záznamu

A randomized titrate-to-target study comparing fixed-dose combinations of azilsartan medoxomil and chlorthalidone with olmesartan and hydrochlorothiazide in stage-2 systolic hypertension

Autor: William C. Cushman, Stuart Kupfer, Eric E. Lloyd, Andrew V. Roberts, Domenic A. Sica, George L. Bakris, Michael A. Weber, William B. White

Publikováno v: Journal of Hypertension

Background: Azilsartan medoxomil (AZL-M), an angiotensin II receptor blocker, has been developed in fixed-dose combinations (FDCs) with chlorthalidone (CTD). Objective/methods: We compared FDCs of AZL-M/CTD 20/12.5 mg once daily titrated to 40/25 mg

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9b0ca70f8cc3e70f46b564bc8885d22
https://doi.org/10.1097/hjh.0000000000001647

Zobrazit plný text záznamu

Cost-effectiveness of nitrendipine and hydrochlorothiazide or metoprolol to treat hypertension in rural community health centers in China

Autor: Guang Hao, Xin Wang, Zengwu Wang, Yang Li, Linfeng Zhang, Zuo Chen, Xin Zhao, Liyuan Ma, Manlu Zhu

Publikováno v: Journal of Hypertension

Supplemental Digital Content is available in the text
Objectives: The objective of this article is to compare blood pressure (BP)-lowing effects of nitrendipine and hydrochlorothiazide and nitrendipine and metoprolol, and estimate the economic e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::928f9d655fc2593de661d9a3e8e741b4
https://doi.org/10.1097/hjh.0000000000001209

Zobrazit plný text záznamu

From one-man bands to harmoniously playing chamber and full orchestras

Autor: Ernst Rietzschel, Marc De Buyzere

Publikováno v: Journal of Hypertension

Objectives: This study evaluated the effectiveness of a structured multidisciplinary risk assessment and management programme for patients with hypertension (RAMP-HT) who were managed in public primary care clinics but had suboptimal blood pressure (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9235c95cbb155b61c0785f1a169f2b85
https://doi.org/10.1097/hjh.0000000000001156

Zobrazit plný text záznamu

Management of hypertension and diabetes mellitus by cardiovascular and endocrine physicians

Autor: Jie Song, Chang-Sheng Sheng, Li-Nong Ji, Qi-Fang Huang, Changsheng Ma, Li-Hua Li, Ji-Guang Wang, Xiao-Hui Guo

Publikováno v: Journal of Hypertension

Objective: We investigated hypertension and diabetes mellitus in two management settings, namely cardiology and endocrinology, and their associations with albuminuria while accounting for the management of these two diseases. Methods: Our multicentre

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3166e52e9acca3b6ea78ca071546f96
https://doi.org/10.1097/hjh.0000000000000994

Zobrazit plný text záznamu

Effects of azilsartan medoxomil compared with olmesartan and valsartan on ambulatory and clinic blood pressure in patients with type 2 diabetes and prediabetes

Autor: Eric E. Lloyd, Stuart Kupfer, René H. Cuadra, William B. White, George L. Bakris

Publikováno v: Journal of Hypertension

Background: Angiotensin receptor blockers (ARBs) are preferred antihypertensive therapies in patients with type 2 diabetes mellitus (T2DM). Azilsartan medoxomil (AZL-M) is a potent ARB for the treatment of stages 1-2 hypertension. We compared the eff

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::26645a6905e8d9347d90cb1733b8659d
http://europepmc.org/articles/PMC4947533

Zobrazit plný text záznamu

Effects of a nationwide strategy to reduce salt intake in Samoa

Autor: Kathy Trieu, Jacqui Webster, Marjory Moodie, Joseph Alvin Santos, Bruce Neal, Mark Woodward, Colin Bell, Taiaopo Faumuina, Wendy Snowdon, Merina Ieremia

Publikováno v: Journal of Hypertension

Objective: Salt reduction is one of the most cost-effective interventions for the prevention of noncommunicable diseases, but there are no studies evaluating the effectiveness of national strategies in low or lower middle income countries. This study

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fc31030dc5459fb277d1a4744d599ae8
http://ora.ox.ac.uk/objects/uuid:

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání